SecBot SecBot
6-K ·Filed Sep 15, 2026

AZN

ASTRAZENECA PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001654954-26-008367
Actionable Insight • Neutral

This is a routine insider purchase by a non-executive chair with no material impact on AZN's valuation or outlook. Monitor for any subsequent larger insider transactions or changes in institutional ownership for broader sentiment signals.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$161.85
T+0 close · Sep 15, 2026 · via day close
Latest settled
−3.73%
T+20 · $155.82 · next T+60 in 22d
Vs SPY
−6.45%
α at T+20
Latest observation
+15.76%
T+43 · FF3 residual α
  1. T+0 · Sep 15 $161.85entry
  2. T+1 · 2mo ago +0.64%α +1.08% · $162.89
  3. T+5 · 8w ago +4.03%α +1.90% · $168.37
  4. T+20 · 5w ago −3.73%α −6.45% · $155.82
  5. T+44 · todayOpen
  6. T+60 · in 22d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AstraZeneca's Non-Executive Chair Michel Demaré purchased 2,500 ordinary shares at £121.21 per share on 14 September 2026, a routine insider buy of approximately £303,000. This is a small, non-material open-market purchase by a non-executive director, representing a modest alignment signal but negligible relative to a $254B market cap. The filing is routine and carries no actionable trading signal.

Key Facts

  • Non-Executive Chair Michel Demaré purchased 2,500 ordinary shares on 14 September 2026.
  • Purchase price was £121.213296 per share, total value approximately £303,033.
  • Transaction was an open-market purchase on the London Stock Exchange (LON).
  • No other material financial or operational information was disclosed in this filing.

Financial Impact

Approximately £303,000 (GBP) open-market purchase by a non-executive director, immaterial relative to $254B market cap.

Risk Factors

  • Insider purchase is too small to signal any material conviction or change in business outlook.
  • No other financial or operational data in this filing to assess company performance.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (35 analysts)

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (AZN), Batch item 10001654954-26-008367
Document: 0001654954-26-008367-index-headers.html0001654954-26-008367
Document: 0001654954-26-008367-index.html0001654954-26-008367
Document: 0001654954-26-008367.txt0001654954-26-008367
6-K Filing (AZN), Batch item 50001654954-26-008367
Document: 0001654954-26-008367-index-headers.html0001654954-26-008367
Document: 0001654954-26-008367-index.html0001654954-26-008367
Document: 0001654954-26-008367.txt0001654954-26-008367

Track record

77 reports on AZN

Performance horizon

19 of 38 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 29 of 38 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
  2. Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.45 −0.59% settles Nov 23
  3. Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.45 −0.46% settles Nov 23
  4. Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.45 −0.35% settles Nov 23
  5. Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.45 −1.28% ▼ −1.32% −4.61% vs SPY
  6. Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.45 −1.14% ▲ +1.51% +1.43% vs SPY
  7. Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.45 −1.14% ▲ +1.51% +1.43% vs SPY
  8. Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.45 −1.18% ▼ −0.12% +2.59% vs SPY
  9. Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.45 +8.45% ▲ +8.11% +10.10% vs SPY
  10. Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.45 +6.88% ▲ +0.51% −0.19% vs SPY
Showing 10 of 77

US Market Status

Market Closed · Opens Wed (12h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026